Reuters Health Report

Click to View in Browser 03/24/2014 U.S. to allow some people to enroll in Obamacare after deadline WASHINGTON (Reuters) - The Obama administration will soon issue new Obamacare guidelines allowing people to enroll in health coverage after a March 31 deadline, but only under certain circumstances, according to sources close to the administration. U.S. top court takes no action in Teva MS drug case WASHINGTON (Reuters) - The U.S. Supreme Court on Monday for the second time did not announce whether it would hear an appeal by Teva Pharmaceutical Industries Ltd in a patent fight with generic competitors over a top-selling multiple sclerosis drug. Mother and child activity levels linked: study NEW YORK (Reuters Health) - The amount of physical activity mothers get is linked to their children's activity levels, according to a new study from the UK. Israel's BrainStorm gets U.S. patent for stem cell technology TEL AVIV (Reuters) - Israel-based BrainStorm Cell Therapeutics said on Monday the U.S. Patent and Trademark Office has granted the company a key patent for its autologous stem cell technology. As many as 32,000 kids infected with drug-resistant TB: report CHICAGO (Reuters) - As many as 32,000 children worldwide become sick each year with a drug-resistant "superbug" strain of tuberculosis, according to new estimates by U.S. researchers that for the first time quantify rates of this difficult-to-treat form of TB. UK cost agency says 'no' to Bayer prostate cancer drug Xofigo LONDON (Reuters) - Britain's healthcare cost agency has recommended against using Bayer's new prostate cancer drug Xofigo on the state health service because the German firm did not provide evidence on how well it worked compared to other therapies. Guinea dispatches equipment to contain outbreak of Ebola CONAKRY (Reuters) - Health officials fighting an outbreak of Ebola in Guinea on Sunday dispatched specialized medical equipment, imposed restrictions on funerals and sought to contain panic to prevent the fever from spreading. Experimental J&J psoriasis drug shows promise in study (Reuters) - An experimental Johnson & Johnson drug for moderate to severe psoriasis proved significantly better at clearing the scaly, uncomfortable skin patches associated with the disease than a placebo, according to data from a midstage study presented on Saturday. Guinea hemorrhagic fever may have crossed into Sierra Leone FREETOWN (Reuters) - An outbreak of hemorrhagic fever that has killed 29 people in Guinea may have spread across the border into neighboring Sierra Leone, according to a World Health Organisation (WHO) document and a senior Sierra Leone health official. Novartis psoriasis drug effective when self-administered - studies ZURICH (Reuters) - Results of two late-stage clinical trials showed high efficacy for Novartis' drug secukinumab when used by patients suffering from moderate-to-severe plaque psoriasis, the Swiss drugmaker said on Saturday. Related Video Autonomous drones learn to fly as a flock Old batteries power new lights in Gaza The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend